Retraction

Interleukin-36 receptor antagonist is associated with the progression of renal cell carcinoma

Retraction Details

Nature of Retraction:

Retraction

Additional Notes:

see also: https://pubpeer.com/publications/39A1613F4546DA16064BA441B29A0F;

Citations (2)

2
Total Citations
1
Post-Retraction
(50.0%)
0
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
0 After 2+ years
150 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma
Lianzi Wang, Shubing Zhang, Huimin Li et al. (8 authors)
BMC Cancer Open Access
Published: Jul 2021
52 citations
150 days after retraction
Quick Stats
Total Citations: 2
Years Since Retraction: 4.7 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Methyl helicterilate ameliorates alcohol-induced hepatic fi…
International Immunopharmacology • 13 citations
Modulation of cytokine and β-defensin 2 expressions in huma…
International Immunopharmacology • 25 citations
Cyanorona-20: The first potent anti-SARS-CoV-2 agent
International Immunopharmacology • 28 citations
Oroxylin A inhibits carcinogen-induced skin tumorigenesis t…
International Immunopharmacology • 24 citations
MiR-92b-3p ameliorates inflammation and autophagy by target…
International Immunopharmacology • 24 citations